Predicting response to neoadjuvant therapy (NAT) in patients (pts) with early-stage breast cancer (BC) using circulating tumor DNA (ctDNA) testing. Artificial intelligence (AI) –powered H&E ...
Real-world outcomes of systemic therapy in penile cancer: A single-center experience from a tertiary referral hospital in Mexico. This is an ASCO Meeting Abstract from the 2026 ASCO Genitourinary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results